259 related articles for article (PubMed ID: 28737526)
1. Serial measurements of neutrophil gelatinase-associated lipocalin: prognostic value in patients with ST-segment elevation myocardial infarction treated with a primary percutaneous coronary intervention.
Lim YM; Moon JY; Min D; Kim SH; Yang WI; Kim WJ; Sung JH; Kim IJ; Lim SW; Cha DH
Coron Artery Dis; 2017 Dec; 28(8):690-696. PubMed ID: 28737526
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as biomarkers of acute kidney injury after ST-segment elevation myocardial infarction treated by percutaneous coronary intervention.
Nguyen LS; Spagnoli V; Kerneis M; Hauguel-Moreau M; Barthélémy O; Collet JP; Montalescot G; Silvain J
Arch Cardiovasc Dis; 2019 Mar; 112(3):180-186. PubMed ID: 30639197
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil Gelatinase-Associated Lipocalin for the Early Prediction of Acute Kidney Injury in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention.
Merdler I; Rozenfeld KL; Zahler D; Shtark M; Goldiner I; Loewenstein IS; Fortis L; Hochstadt A; Keren G; Banai S; Shacham Y
Cardiorenal Med; 2020; 10(3):154-161. PubMed ID: 32155621
[TBL] [Abstract][Full Text] [Related]
4. Correlation and prognostic role of neutrophil to lymphocyte ratio and SYNTAX score in patients with acute myocardial infarction treated with percutaneous coronary intervention: A six-year experience.
Zuin M; Rigatelli G; Picariello C; dell'Avvocata F; Marcantoni L; Pastore G; Carraro M; Nanjundappa A; Faggian G; Roncon L
Cardiovasc Revasc Med; 2017 Dec; 18(8):565-571. PubMed ID: 28529092
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of SYNTAX score II for clinical outcomes in cardiogenic shock underwent primary percutaneous coronary intervention; a pilot study.
Hayıroğlu Mİ; Keskin M; Uzun AO; Bozbeyoğlu E; Yıldırımtürk Ö; Kozan Ö; Pehlivanoğlu S
Int J Cardiovasc Imaging; 2018 Mar; 34(3):329-336. PubMed ID: 28889354
[TBL] [Abstract][Full Text] [Related]
6. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Lindberg S; Pedersen SH; Mogelvang R; Jensen JS; Flyvbjerg A; Galatius S; Magnusson NE
J Am Coll Cardiol; 2012 Jul; 60(4):339-45. PubMed ID: 22813613
[TBL] [Abstract][Full Text] [Related]
7. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.
Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582112
[TBL] [Abstract][Full Text] [Related]
8. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Gao M; Cheng Y; Zheng Y; Zhang W; Wang L; Qin L
BMC Cardiovasc Disord; 2017 Jan; 17(1):43. PubMed ID: 28129742
[TBL] [Abstract][Full Text] [Related]
9. Discordant cardiac biomarker levels independently predict outcome in ST-segment elevation myocardial infarction.
Leibundgut G; Gick M; Morel O; Ferenc M; Werner KD; Comberg T; Kienzle RP; Buettner HJ; Neumann FJ
Clin Res Cardiol; 2016 May; 105(5):432-40. PubMed ID: 26563201
[TBL] [Abstract][Full Text] [Related]
10. Elevated Neutrophil Gelatinase-Associated Lipocalin for the Assessment of Structural versus Functional Renal Damage among ST-Segment Elevation Myocardial Infarction Patients.
Rozenfeld KL; Zahler D; Shtark M; Goldiner I; Keren G; Banai S; Shacham Y
Blood Purif; 2020; 49(5):560-566. PubMed ID: 32074603
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of neutrophil gelatinase-associated lipocalin and glycosylated hemoglobin for non-ST-segment elevation myocardial infarction patients with single concomitant chronic total occlusion following primary percutaneous coronary intervention: A prospective observational study.
Peng W; Zhang C; Wang Z; Yang W; Luo H; Li X; Fu D; Yu C; Zhou Y
Medicine (Baltimore); 2019 Sep; 98(39):e16982. PubMed ID: 31574797
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y
J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809
[TBL] [Abstract][Full Text] [Related]
13. Elevated neutrophil gelatinase-associated lipocalin levels before contrast media administration among ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
Rozenfeld KL; Zahler D; Shtark M; Goldiner I; Keren G; Shacham Y
Coron Artery Dis; 2020 Mar; 31(2):118-123. PubMed ID: 31145117
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of neutrophil gelatinase-associated lipocalin in ST-segment elevation myocardial infarction.
Akcay AB; Ozlu MF; Sen N; Cay S; Ozturk OH; Yalcn F; Bilen P; Kanat S; Karakas MF; Isleyen A; Demir AD; Sogut S; Covic A; Kanbay M
J Investig Med; 2012 Feb; 60(2):508-13. PubMed ID: 22222228
[TBL] [Abstract][Full Text] [Related]
15. Acute Kidney Injury After Primary Angioplasty: Is Contrast-Induced Nephropathy the Culprit?
Caspi O; Habib M; Cohen Y; Kerner A; Roguin A; Abergel E; Boulos M; Kapeliovich MR; Beyar R; Nikolsky E; Aronson D
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28647690
[TBL] [Abstract][Full Text] [Related]
16. Growth differentiation factor-15 as a negative predictor for microvascular obstruction in ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
Wu X; Bai J; Tan Y; Wei Z; Dai Q; Kang L; Wang L; Chen J; Yang Y; Wang K; Wu H
Int J Cardiovasc Imaging; 2024 Apr; 40(4):863-871. PubMed ID: 38430425
[TBL] [Abstract][Full Text] [Related]
17. Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Kolte D; Spence N; Puthawala M; Hyder O; Tuohy CP; Davidson CB; Sheldon MW; Laskey WK; Abbott JD
Cardiovasc Revasc Med; 2016 Dec; 17(8):546-551. PubMed ID: 27566903
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Prolonged In-Hospital Stay After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
Isik T; Ayhan E; Uluganyan M; Gunaydin ZY; Uyarel H
Angiology; 2016 Sep; 67(8):756-61. PubMed ID: 26582944
[TBL] [Abstract][Full Text] [Related]
19. Primary Percutaneous Coronary Intervention Versus In-hospital thrombolysis as Reperfusion Therapy in Early-Arriving Low-risk STEMI Patients.
Levi Y; Frimerman A; Shotan A; Shochat M; Blondheim DS; Segev A; Goldenerg I; Kazatsker M; Vasilenko L; Shlomo N; Meisel SR
Isr Med Assoc J; 2017 Jun; 19(6):345-350. PubMed ID: 28647930
[TBL] [Abstract][Full Text] [Related]
20. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.
Miyachi H; Takagi A; Miyauchi K; Yamasaki M; Tanaka H; Yoshikawa M; Saji M; Suzuki M; Yamamoto T; Shimizu W; Nagao K; Takayama M
Heart Vessels; 2016 Nov; 31(11):1740-1751. PubMed ID: 26758733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
